DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $30.00 at The Goldman Sachs Group

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price reduced by The Goldman Sachs Group from $34.00 to $30.00 in a research report released on Monday morning, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the medical instruments supplier’s stock.

XRAY has been the subject of several other reports. SVB Leerink assumed coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an outperform rating and a $42.00 target price for the company. Evercore ISI lowered their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an outperform rating on the stock in a research report on Friday, May 3rd. Needham & Company LLC reduced their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research report on Friday, May 3rd. Piper Sandler restated a neutral rating and set a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Finally, Leerink Partnrs reiterated an outperform rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA has an average rating of Moderate Buy and an average target price of $35.22.

DENTSPLY SIRONA Trading Up 1.4 %

NASDAQ XRAY opened at $28.20 on Monday. The stock has a market capitalization of $5.86 billion, a P/E ratio of -64.09, a P/E/G ratio of 1.24 and a beta of 1.00. The business has a 50 day simple moving average of $31.71 and a 200 day simple moving average of $32.60. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. During the same period in the prior year, the business earned $0.39 EPS. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. Research analysts expect that DENTSPLY SIRONA will post 2.03 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a dividend of $0.16 per share. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently added to or reduced their stakes in the company. VisionPoint Advisory Group LLC boosted its stake in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares during the last quarter. Principal Securities Inc. bought a new stake in DENTSPLY SIRONA during the fourth quarter worth $26,000. Headlands Technologies LLC purchased a new position in DENTSPLY SIRONA in the fourth quarter worth $30,000. Parkside Financial Bank & Trust grew its stake in DENTSPLY SIRONA by 33.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares during the period. Finally, Anchor Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $47,000. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.